Jackson Financial Inc. (JXN) Q4 2024 Earnings Summary
Executive Summary
- Q4 2024 delivered strong non-GAAP performance: Adjusted Operating Earnings (AOE) were $349 million ($4.65 per diluted share), up 71% y/y on higher variable annuity AUM and spread income; GAAP net income was $334 million ($4.45 diluted EPS), with non-operating volatility largely offset by hedging .
- Retail annuity sales rose 42% y/y to $4.7B, led by variable annuities at $2.8B (+27%), RILA at $1.5B (+47%), and fixed/fixed index at $397M (vs. $79M) .
- Capital position strengthened: JNLIC statutory TAC increased to $5.1B and RBC to 572%; holding company liquidity exceeded $700M; Q4 capital returned to shareholders was $148M .
- 2025 guidance/capital actions: Dividend raised 14% to $0.80; capital return target increased to $700–$800M; management expects >$1B free capital generation under normal conditions .
- Consensus estimates from S&P Global were unavailable at request time; we cannot quantify beats/misses vs. Street for Q4 2024.
What Went Well and What Went Wrong
What Went Well
- Sales diversification and scale: Retail annuity sales reached $4.7B (+42% y/y) with every category growing; RILA $1.5B (+47%), VA $2.8B (+27%), fixed $397M (vs. $79M) .
- Operating earnings momentum: Q4 AOE $349M ($4.65), up from $204M ($2.53) y/y; drivers included higher fee income from larger average VA AUM and improved spread income; reduced diluted share count aided EPS .
- Capital strength and cash generation: Statutory TAC rose to $5.1B; RBC improved to 572%; holding company liquidity exceeded $700M; Q4 distribution of $280M to parent contributed to full-year distributions of $875M .
- CEO tone: “2024 was a tremendous year… gives us confidence in our $700–800 million capital return target for 2025” .
What Went Wrong
- Assumption review impacts: Annual actuarial updates reduced Q4 earnings by $23M after-tax (~$0.31 per share); non-operating impact was $419M tied to refined withdrawal frequency modeling for GMWB policies .
- Variable annuity net outflows elevated amid strong markets and policy vintages exiting surrender periods; management noted 9% average VA account value increase and higher fee income as offsets .
- Corporate & Other remained a drag: Q4 pretax adjusted operating loss of $(57)M (flat y/y), and full-year corporate loss widened to $(264)M on lower investment income and reinsurance-related adjustment .
Financial Results
Consolidated Results (GAAP and Non-GAAP)
Notes: GAAP revenue reflects fee income, premiums, net investment income and fair value marks; Q4’s low total revenues reflect significant net losses on derivatives/investments and funds withheld marks offset by MRB gains .
Segment Pretax Adjusted Operating Earnings ($USD Millions)
KPIs and Sales Mix
Guidance Changes
Earnings Call Themes & Trends
Management Commentary
- CEO: “2024 was a pivotal year… distributions to our holding company of $875 million, the highest annual level… RBC… 572%… free cash flow of $767 million and $631 million of capital return… increased our total capital return target to $700 million to $800 million” .
- CFO: “Adjusted operating earnings of $349 million were up 71%… EPS $4.65; adjusting for notable items and tax rate, $4.84… assumption review unfavorable $0.31; guarantee fees $0.8B in Q4 and $3.1B for the year… net hedge result gain $79M” .
- CFO on Brooke Re: “Capital for the full year increased by about $200 million… minimum operating capital maintained well above threshold” .
- CEO on distribution: “Introduced a RILA product in New York, partnered with JPMorgan Chase… added a GMAB to Elite Access” .
Q&A Highlights
- Brooke Re transparency and capital: Management reiterated modified GAAP framework, long-term stability focus, and minimum operating capital guardrails; will disclose if capital is added/removed and provide annual updates; Brooke Re capital up ~$200M in 2024 .
- Assumption review: Refinement targeted withdrawal frequency granularity (not utilization directly); operating impact ~$26M unfavorable (mortality), non-operating impact $419M; surrender assumptions unchanged; at-/in-the-money lapse ~8–9% .
- Capital return pacing: Excess capital exists at both opco and holdco; RBC buffer to decline gradually rather than via one transaction; 66–80% of capital generation distributed in 2024 depending on CAMT normalization .
- PPM strategy: Core to general account and third-party business; recent EM debt team hire expands capabilities; potential to grow within Jackson strategy over time .
Estimates Context
- S&P Global consensus estimates (EPS, Revenue, EBITDA, Target Price) were unavailable at request time due to API limits. As a result, we cannot quantify beats/misses vs. Street for Q4 2024. If needed, we can refresh and compare once access is restored.
Key Takeaways for Investors
- Non-GAAP operating momentum continues: Q4 AOE per share of $4.65 sustained despite actuarial headwinds; fee income and spread earnings underpin trajectory .
- Sales engine broadening: RILA and fixed products complement VA, reducing reliance on living-benefit VA while supporting hedging efficiency; JPMorgan channel adds scale .
- Capital strength and disciplined returns: RBC at 572% with rising TAC and >$700M holdco liquidity supports 2025 capital return raised to $700–$800M and dividend lift to $0.80 .
- Hedging program enhancing stability: Net hedge gains and better MRB alignment are reducing non-operating volatility; guarantee fee stream remains robust .
- Watch VA outflow dynamics: Elevated outflows likely persist in strong markets and as vintages roll; management holds surrender assumptions steady and highlights AUM/fee resilience .
- Brooke Re remains self-sustaining with guardrails: Capital grew ~$200M in 2024; disclosures to remain periodic, with thresholds above minimum operating capital .
- Near-term trading lens: Positive catalysts include dividend increase, increased capital return target, and strong sales mix; risks include actuarial review impacts and market-driven non-op swings (interest rate sensitivity) .